McGough William C, Sanchez Lorena E, McCague Cathal, Stewart Grant D, Schönlieb Carola-Bibiane, Sala Evis, Crispin-Ortuzar Mireia
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
Department of Oncology, University of Cambridge, Cambridge, UK.
Camb Prism Precis Med. 2022 Nov 11;1:e4. doi: 10.1017/pcm.2022.9. eCollection 2023.
Renal cancer is responsible for over 100,000 yearly deaths and is principally discovered in computed tomography (CT) scans of the abdomen. CT screening would likely increase the rate of early renal cancer detection, and improve general survival rates, but it is expected to have a prohibitively high financial cost. Given recent advances in artificial intelligence (AI), it may be possible to reduce the cost of CT analysis and enable CT screening by automating the radiological tasks that constitute the early renal cancer detection pipeline. This review seeks to facilitate further interdisciplinary research in early renal cancer detection by summarising our current knowledge across AI, radiology, and oncology and suggesting useful directions for future novel work. Initially, this review discusses existing approaches in automated renal cancer diagnosis, and methods across broader AI research, to summarise the existing state of AI cancer analysis. Then, this review matches these methods to the unique constraints of early renal cancer detection and proposes promising directions for future research that may enable AI-based early renal cancer detection via CT screening. The primary targets of this review are clinicians with an interest in AI and data scientists with an interest in the early detection of cancer.
肾癌每年导致超过10万人死亡,主要是在腹部计算机断层扫描(CT)中被发现。CT筛查可能会提高早期肾癌的检出率,并提高总体生存率,但预计其经济成本过高。鉴于人工智能(AI)的最新进展,通过自动化构成早期肾癌检测流程的放射学任务,有可能降低CT分析成本并实现CT筛查。本综述旨在通过总结我们目前在人工智能、放射学和肿瘤学方面的知识,并为未来的新工作提出有用的方向,促进早期肾癌检测方面的进一步跨学科研究。首先,本综述讨论了自动肾癌诊断的现有方法以及更广泛的人工智能研究中的方法,以总结人工智能癌症分析的现有状态。然后,本综述将这些方法与早期肾癌检测的独特限制相匹配,并为未来研究提出有前景的方向,这些研究可能通过CT筛查实现基于人工智能的早期肾癌检测。本综述的主要目标是对人工智能感兴趣的临床医生和对癌症早期检测感兴趣的数据科学家。